CLINICAL_TRIALS
trial_result
· 2019-11-12
Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1 [Phase 1]
Summary
Phase 1 trial update evaluating safety and immunogenicity of the malaria vaccine R21 with and without Matrix-M1.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2019-11-12